Clinical Trials · NCT01615978
Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 15
- Start date
- Dec 2003
- Locations
- 1 site, Japan
- Primary endpoint
- 24-hour profiles of serum calcitonin